Efor Expands Its Asian Operations Through No Deviation Acquisition

Efor, renowned for its expertise in quality and compliance within the Life Sciences sector, has announced a pivotal acquisition of No Deviation, a Singapore-based firm specializing in various compliance services. Founded in 2013, Efor has developed a robust global presence with over 3,000 professionals operating across 18 countries. This acquisition marks a significant leap forward in Efor's strategy to bolster its influence within Asian markets, where it recently added more than 300 professionals to its workforce.

No Deviation, established in 2007, is recognized for its competency in Commissioning, Qualification Validation (CQV), and Computer System Validation (CSV). The company operates primarily out of Singapore, extending its services to China and Ireland as well. Their headquarters in Singapore has allowed them to cultivate strong capabilities in fast-paced biopharmaceutical settings, offering local expertise that is essential for navigating the complex landscape of Life Sciences in Asia.

This merger not only strengthens Efor's regional capabilities but also underscores the company's commitment to delivering high-quality compliance solutions across diverse industrial projects. According to Mathieu Roger, the Founder and President of Efor,